Minerva Neurosciences | NERV - EPS Earnings Per Share


Minerva Neurosciences reported $-0.56 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Adma Biologics USD 0.19 0.01 Mar/2026
ALKERMES USD 0 0.4 Jun/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
AstraZeneca USD 2.63 0.05 Jun/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Cipla INR 9.76 2.9 Jun/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
CSL USD 5.07 3 Dec/2025
Eli Lilly USD 8.38 0.17 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Merck USD -0.13 1.15 Jun/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.77 0.02 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 2.09 0.21 Jun/2026
Takeda JPY 71.65 87.21 Jun/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024